Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.04% |
| 3 | Financials | 12.69% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Aveanna Healthcare
AVAH
$2.46B
| $104K | ﹤0.01% |
132,979
-61
| -0% | -$64 |
|
|
OPTN
3927
DELISTED
OptiNose
OPTN
| $103K | ﹤0.01% |
3,724
-359
| -9% | -$13.6K |
|
3928
AST SpaceMobile
ASTS
$21.4B
| $103K | ﹤0.01% |
21,414
| – | – |
|
|
CNCE
3929
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $102K | ﹤0.01% |
17,528
-102,732
| -85% | -$540K |
|
3930
Kartoon Studios
TOON
$38.2M
| $102K | ﹤0.01% |
21,828
-60
| -0.3% | -$387 |
|
3931
CorMedix
CRMD
$639M
| $101K | ﹤0.01% |
24,016
-62
| -0.3% | -$219 |
|
|
SPRB
3932
Spruce Biosciences
SPRB
$143M
| $101K | ﹤0.01% |
1,228
-9
| -0.7% | -$753 |
|
|
WEJO
3933
DELISTED
Wejo Group Limited Common Shares
WEJO
| $101K | ﹤0.01% |
209,592
+29,261
| +16% | +$26.2K |
|
3934
Kopin
KOPN
$898M
| $100K | ﹤0.01% |
81,018
-385
| -0.5% | -$476 |
|
|
GPGI
3935
GPGI Inc
GPGI
$3.75B
| $100K | ﹤0.01% |
24,615
| – | – |
|
|
OMGA
3936
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $100K | ﹤0.01% |
+17,522
| New | +$98.3K |
|
|
TCON
3937
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $99.2K | ﹤0.01% |
3,330
-22
| -0.7% | -$665 |
|
|
AUD
3938
DELISTED
Audacy, Inc.
AUD
| $97.2K | ﹤0.01% |
431,699
| – | – |
|
3939
TransAlta
TAC
$3.99B
| $96.8K | ﹤0.01% |
10,794
+783
| +8% | +$7.01K |
|
3940
SoundHound AI
SOUN
$3.32B
| $96.3K | ﹤0.01% |
54,380
| – | – |
|
3941
Magnachip Semiconductor
MX
$137M
| $96.1K | ﹤0.01% |
10,234
| – | – |
|
|
ZOM
3942
DELISTED
Zomedica Corp.
ZOM
| $94.6K | ﹤0.01% |
580,391
-1,127
| -0.2% | -$231 |
|
3943
Acacia Research
ACTG
$449M
| $93.7K | ﹤0.01% |
22,253
| – | – |
|
3944
Cipher Digital
CIFR
$6.9B
| $93.6K | ﹤0.01% |
167,169
| – | – |
|
3945
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.09B
| $93.6K | ﹤0.01% |
+12,399
| New | +$94.9K |
|
3946
IAMGOLD
IAG
$10.1B
| $92.9K | ﹤0.01% |
36,003
-6,237
| -15% | -$10.8K |
|
3947
Kaltura
KLTR
$243M
| $92.6K | ﹤0.01% |
+53,824
| New | +$98.9K |
|
3948
DNA X Inc
SONM
$5.05M
| $92.4K | ﹤0.01% |
1,208
-10
| -0.8% | -$822 |
|
|
MTCR
3949
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $91.4K | ﹤0.01% |
204,023
-1,593
| -0.8% | -$659 |
|
3950
Stereotaxis
STXS
$137M
| $91.3K | ﹤0.01% |
44,091
-138
| -0.3% | -$270 |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.